17 alpha-hydroxyprogesterone caproate has been researched along with medroxyprogesterone in 13 studies
| Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (medroxyprogesterone) | Trials (medroxyprogesterone) | Recent Studies (post-2010) (medroxyprogesterone) |
|---|---|---|---|---|---|
| 517 | 88 | 251 | 3,530 | 490 | 135 |
| Protein | Taxonomy | 17 alpha-hydroxyprogesterone caproate (IC50) | medroxyprogesterone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.019 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.019 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.137 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.019 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.019 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.019 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (61.54) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Titova, VA; Voznyĭ, EK | 1 |
| Bobrov, IuF; Bokhman, IaV; Fel'dkoren, BI; Tsyrlina, EV; Vishnevskiĭ, AS | 1 |
| Ashkenazy, M; Czernobilsky, B; Kessler, I; Lancet, M; Nahshoni, A | 1 |
| Fujimoto, J; Fujita, H; Nakata, Y; Okada, H | 1 |
| Bruen, JA; Hick, JF; Kurland, LT; Noller, KL; O'Fallon, WM; Resseguie, LJ | 1 |
| Roopnarinesingh, S | 1 |
| Bauer, J; Papez, L | 1 |
| Das Gupta, V | 1 |
| Charkviani, L; Charkviani, T; Kobiashvili, H | 1 |
| Arai, F; Chekir, C; Emi, Y; Hiramatsu, Y; Kamada, Y; Kikuchi, Y; Matsuda, M; Nakatsuka, M; Sasaki, A; Shimizu, K; Tabuchi, K | 1 |
1 review(s) available for 17 alpha-hydroxyprogesterone caproate and medroxyprogesterone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for 17 alpha-hydroxyprogesterone caproate and medroxyprogesterone
| Article | Year |
|---|---|
Acceptability of drugs for male fertility regulation: a prospectus and some preliminary data. World Health Organization Task Force on Psychosocial Research in Family Planning.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Clinical Trials as Topic; Contraceptive Agents, Male; Contraceptive Devices, Male; Cyproterone; Cyproterone Acetate; Humans; Hydroxyprogesterones; Libido; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Sexual Behavior; Testosterone; Vasectomy; World Health Organization | 1980 |
11 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and medroxyprogesterone
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Progestins in combined treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Progestins; Uterine Neoplasms | 1990 |
[Effect of progestin therapy on the level of cytoplasmic receptors in patients with cancer of the corpus uteri].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents; Cytoplasm; Drug Evaluation; Female; Homeostasis; Humans; Hydroxyprogesterones; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Preoperative Care; Receptors, Cell Surface; Reproduction; Uterine Neoplasms; Vaginal Smears | 1989 |
Ovarian tumors in pregnancy.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abortion, Spontaneous; Adult; Combined Modality Therapy; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Ovariectomy; Pregnancy; Pregnancy Complications, Neoplastic | 1988 |
[Hormone dependency and progestogen therapy in the treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cell Division; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Norethindrone; Tamoxifen; Tumor Stem Cell Assay; Uterine Neoplasms | 1987 |
Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abnormalities, Drug-Induced; Ethisterone; Female; Fetal Death; Humans; Hydroxyprogesterones; Infant, Newborn; Male; Maternal-Fetal Exchange; Medroxyprogesterone; Minnesota; Norethindrone; Pregnancy; Prenatal Exposure Delayed Effects; Progesterone; Progestins | 1985 |
Evaluation of progestational agents for postmenopausal hot flushes.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Climacteric; Double-Blind Method; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Progesterone Congeners | 1982 |
[Prevention of dysfunctional metrorrhagia in the climacteric].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Climacteric; Clomiphene; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Metrorrhagia; Middle Aged | 1983 |
Quantitation of hydroxyprogesterone caproate, medroxyprogesterone acetate, and progesterone by reversed-phase high-pressure liquid chromatography.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Chromatography, High Pressure Liquid; Drug Stability; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Progesterone; Suspensions; Tablets | 1982 |
Organ preserving method in the management of atypical endometrial hyperplasia.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Administration, Oral; Adult; Endometrial Hyperplasia; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pregnancy; Progesterone Congeners | 2001 |
Altered arterial stiffness in male-to-female transsexuals undergoing hormonal treatment.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Administration, Oral; Adult; Cross-Sectional Studies; Drug Implants; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hydroxyprogesterones; Japan; Male; Medroxyprogesterone; Middle Aged; Progestins; Transsexualism; Vascular Diseases; Vascular Stiffness | 2012 |